RxDoctor Payments Data

Shawana Moore

Women's Health · Philadelphia, PANPI 1992070551

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (47.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Biogen at 51.4% of the total. 2025 is the largest year on record at $41,459, more than ten times the $34 reported in 2021. Among women's health clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$71,837in general payments, 2019–2025

Across 148 payments — averaging $485.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$37K
  • Pfizer$17K
  • Astellas Pharma US Inc$11K
  • Shield Therapeutics Inc$2K
  • Coopersurgical, Inc.$2K
  • AbbVie$1K
  • plus $858 from 9 others

What the payments were for

  • Consulting fees$22,98432%
  • Speaking & faculty fees$34,02647%
  • Travel & lodging$11,73516%
  • Food & beverage$3,0924%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$71,837 in reported general payments places this provider in the 95th percentile of 250 women's health providers in Pennsylvania.

See all women's health providers in Pennsylvania

Other women's health in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →